Metabolic engineering Corynebacterium glutamicum for production of γ-aminobutyric acid by glutamate decarboxylase active at near-neutral pH and displaying at cell surface
{"title":"Metabolic engineering Corynebacterium glutamicum for production of γ-aminobutyric acid by glutamate decarboxylase active at near-neutral pH and displaying at cell surface","authors":"Haoqian Li , Hao Yang , Feng Shi","doi":"10.1016/j.procbio.2025.07.002","DOIUrl":null,"url":null,"abstract":"<div><div>γ-Aminobutyric acid (GABA) is widely applied in pharmaceuticals, foods and feeds. <em>Corynebacterium glutamicum</em> that expresses exogenous glutamate decarboxylase (GAD) gene <em>gad</em> can produce GABA from glucose using self-produced L-glutamate. However, the incongruity between optimal pH for cell growth (7.0–7.5) and GAD (4.0–5.0) severely restricts the production of GABA. In this study, several GADs active at near-neutral pH were separately expressed in <em>C. glutamicum</em> by plasmid<em>, Ls</em>GAD derived from <em>Lactobacillus senmaizukei</em> performed better and generated 10.9 g/L GABA. Subsequently, to perform the GAD reaction at the more acidic extracellular environment, <em>Ls</em>GAD was displayed on cell surface by several anchoring motifs, and displaying by PorH and NCgl1307 motifs produced 9.9 g/L and 1.3 g/L GABA, respectively. To further improve GABA production, the metabolic pathways were modified and accompanied by integrating several <em>gad</em> genes in the chromosome, the best strain GSL-6 could produce 15.6 g/L GABA. Finally, the surface display plasmid of <em>Ls</em>GAD was introduced into the chromosomally modified strain GSL-6 to catalyze GAD reaction both intracellularly and extracellularly, and 25.3 g/L and 42.3 g/L GABA was finally produced by shake flask and fed-batch fermentation, respectively. Thereby, this synergistic strategy is beneficial for GABA production in <em>C. glutamicum</em>.</div></div>","PeriodicalId":20811,"journal":{"name":"Process Biochemistry","volume":"157 ","pages":"Pages 75-83"},"PeriodicalIF":3.7000,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Process Biochemistry","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1359511325001977","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
γ-Aminobutyric acid (GABA) is widely applied in pharmaceuticals, foods and feeds. Corynebacterium glutamicum that expresses exogenous glutamate decarboxylase (GAD) gene gad can produce GABA from glucose using self-produced L-glutamate. However, the incongruity between optimal pH for cell growth (7.0–7.5) and GAD (4.0–5.0) severely restricts the production of GABA. In this study, several GADs active at near-neutral pH were separately expressed in C. glutamicum by plasmid, LsGAD derived from Lactobacillus senmaizukei performed better and generated 10.9 g/L GABA. Subsequently, to perform the GAD reaction at the more acidic extracellular environment, LsGAD was displayed on cell surface by several anchoring motifs, and displaying by PorH and NCgl1307 motifs produced 9.9 g/L and 1.3 g/L GABA, respectively. To further improve GABA production, the metabolic pathways were modified and accompanied by integrating several gad genes in the chromosome, the best strain GSL-6 could produce 15.6 g/L GABA. Finally, the surface display plasmid of LsGAD was introduced into the chromosomally modified strain GSL-6 to catalyze GAD reaction both intracellularly and extracellularly, and 25.3 g/L and 42.3 g/L GABA was finally produced by shake flask and fed-batch fermentation, respectively. Thereby, this synergistic strategy is beneficial for GABA production in C. glutamicum.
期刊介绍:
Process Biochemistry is an application-orientated research journal devoted to reporting advances with originality and novelty, in the science and technology of the processes involving bioactive molecules and living organisms. These processes concern the production of useful metabolites or materials, or the removal of toxic compounds using tools and methods of current biology and engineering. Its main areas of interest include novel bioprocesses and enabling technologies (such as nanobiotechnology, tissue engineering, directed evolution, metabolic engineering, systems biology, and synthetic biology) applicable in food (nutraceutical), healthcare (medical, pharmaceutical, cosmetic), energy (biofuels), environmental, and biorefinery industries and their underlying biological and engineering principles.